Nanjing Pharmaceutical Group Company Limited Class ASSE: 600713

Announcement on Convening Performance Briefing for 2025 and Q1 2026

· Issued by Nanjing Pharmaceutical Group Company Limited Class A via Shanghai Stock Exchange
Announcement on Convening Performance Briefing for 2025 and Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment